Log in to your Inderes Free account to see all free content on this page.
QUIA PHARMA
0.017
SEK
+3.61 %
QUIA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Be the first to follow this company
+3.61%
-55.9%
-33.85%
-75.07%
-73.98%
-80.67%
-99.93%
-99.99%
-100%
QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Read moreMarket cap
25.63M SEK
Turnover
45K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
26.2.
2025
Annual report '24
ShowingAll content types
QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.
QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio